Targeting miR-17 to Address the Genetic Cause of ADPKD
Time: 4:30 pm
day: Day Two
Details:
- Advancing biomarker translational research in PKD to elucidate therapeutic efficacy
- Addressing root causes of ADPKD with anti-miRs
- Clinical development of 2nd generation inhibitor RGLS8429
